Hiring Advice

As hybrid working has become the norm for many, employers and candidates are navigating a new era of workplace expectations.

For the past few years, many clinical development hiring processes have been shaped by a market that favors employers. Candidates had fewer opportunities available to them, organizations could afford to be more selective, and hiring decisions often took longer as companies weighed up their options.

As hiring activity picks up, employers are placing greater emphasis on experience, study ownership and long-term impact, not just job titles. They are also facing a new challenge: distinguishing genuine market disruption from career moves that may have come too quickly.

Senior CDMO hiring can stall when expectations become too narrow. Discover how hiring managers can balance precision with flexibility to secure stronger talent.

Biopharma dealmaking is accelerating again, and the hiring market is moving with it. After a slower period for acquisitions in 2024, 2025 saw a major rebound in pharmaceutical M&A activity, with aggregate deal value more than doubling year-over-year to exceed $130 billion globally.

Pharma M&A is driving a biopharma hiring surge in 2026. EPM Scientific's Kristiaan Rawlings discusses salaries, market access demand, and what candidates need to win.

How do you relocate critical medical device manufacturing without disrupting supply? Discover how specialist talent enabled a seamless product transfer.

Explore how agentic AI is changing life sciences workflows across discovery, clinical development, regulatory affairs, and hiring, including the rise of Gemini for Science.

When a global pharmaceutical manufacturer faced revenue loss due to halted U.S. imports, EPM Scientific helped build a specialist remediation team at speed.